Literature DB >> 18358228

A protocol for immunoaffinity separation of the accumulated ubiquitin-protein conjugates solubilized with sodium dodecyl sulfate.

Yohta Shimada1, Takahiro Fukuda, Katsuhiko Aoki, Toyokazu Yukawa, Shawichi Iwamuro, Kiyoshi Ohkawa, Koji Takada.   

Abstract

Certain proteins insoluble in aqueous salt solutions are difficult to separate from impurities by immunoaffinity techniques, even when the proteins are solubilized with denaturants due to interference of the antigen-antibody reaction. Representative examples of such proteins are the ubiquitin-protein conjugates that accumulate in neuronal tissues of neurodegenerative diseases, the hallmark of such disorders. In this study, we developed a novel sample preparation method comprising two successive steps: Sodium dodecyl sulfate (SDS) removal from the SDS-containing extracts and renaturation of the denatured proteins. The application of this method was tested on ubiquitin-protein conjugates in the brains of Niemann-Pick type C disease mouse and in heat-shocked K562 erythroleukemia cells. The ubiquitin-protein conjugates in both cases are insoluble in Tris-buffered saline but soluble in 2% SDS. The SDS-solubilized fractions prepared from each of the samples were further pretreated by the method mentioned above, and the ubiquitin-protein conjugates were efficiently immunoprecipitated with the anti-ubiquitin antibody from them. This method was also applied successfully to the immunoprecipitation of flotillin-1, a lipid raft protein, from mouse brain extract prepared with 2% SDS. These results indicate that this simple protocol has potential applications for excellent immunoaffinity separation of the less-soluble proteins in diverse cells and tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358228     DOI: 10.1016/j.ab.2008.02.031

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  SUMO2/3 is associated with ubiquitinated protein aggregates in the mouse neocortex after middle cerebral artery occlusion.

Authors:  Karin Hochrainer; Katherine Jackman; Corinne Benakis; Josef Anrather; Costantino Iadecola
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-29       Impact factor: 6.200

2.  Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice.

Authors:  Koichiro Haruki; Hiroaki Shiba; Yuki Fujiwara; Kenei Furukawa; Ryota Iwase; Tadashi Uwagawa; Takeyuki Misawa; Toya Ohashi; Katsuhiko Yanaga
Journal:  Dig Dis Sci       Date:  2012-07-18       Impact factor: 3.199

3.  Nuclear factor κB activity correlates with the progression and prognosis of pancreatic cancer in a mouse model.

Authors:  Kenei Furukawa; Tadashi Uwagawa; Koichiro Haruki; Yuki Fujiwara; Tomonori Iida; Hiroaki Shiba; Takeyuki Misawa; Toya Ohashi; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2012-08-15       Impact factor: 2.549

4.  Use of biotinylated ubiquitin for analysis of rat brain mitochondrial proteome and interactome.

Authors:  Olga A Buneeva; Marina V Medvedeva; Arthur T Kopylov; Victor G Zgoda; Alexei E Medvedev
Journal:  Int J Mol Sci       Date:  2012-09-14       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.